Category: Press Releases
Ichor Life Sciences Acquires Woodland Biosciences, Inc.
December 22, 2021
Woodland Biosciences, which studies metabolism and cancer, has joined the holdings of Ichor Life Sciences. Ichor intends to use Woodland’s expertise and research to increase the specializations of its pharmacological
New Partnership Between Forever Healthy and Buck Institute
December 15, 2021
Yet another group has formed to advance early-stage biotechnology research. This time, the Forever Healthy Foundation, founded by Michael Greve, has formed a $5 million partnership with the Buck Institute
Apollo Health Ventures Closes $180 Million Fund
December 2, 2021
Apollo Health Ventures, a venture capitalist firm focusing on rejuvenation biotechnology, has raised $180 million in order to fund companies developing interventions that target age-related diseases. We have included the
Longevica to Launch an Open Research Platform
November 29, 2021
Longevica, a company focused on the biology of aging, has raised $2.5 million dollars for its platform that it hopes will accelerate life extension research. We have included the full
Maximon Launches Longevity Co-Investment Fund
October 7, 2021
The venture capitalist firm Maximon has announced a new longevity-focused fund that focuses on financing early-stage biotechnology companies that increase human healthspan. The firm intends to invest 100 million Swiss
Transhuman Coin Debuts on International Markets
September 30, 2021
A novel cryptocurrency, Transhuman Coin, has recently announced its debut. When a transaction occurs, this coin is automatically distributed back into funding its own growth and the development of research
The Longevity Science Foundation Launches
September 30, 2021
The Longevity Science Foundation has launched today. This new Swiss foundation has confirmed that it will be committing over $1 billion in the next ten years to research, institutions, and
Underdog Pharmaceuticals Concludes $10M Financing Round
September 23, 2021
The investment company Kizoo has announced that one of the companies in its portfolio, Underdog Pharmaceuticals, has received $10 million in funding from a Series Seed II round. Mike Kope,
Underdog Pharmaceuticals Receives Accelerated Designation
September 10, 2021
Underdog Pharmaceuticals (Now called Cyclarity Therapeautics) has just issued a press release announcing that UDP-003, a compound being studied for its effectiveness against oxidized cholesterol, has been given an Innovation
The Longevity Investors Conference
August 24, 2021
Press Release The second investors only conference focusing on Longevity will take place on the 27th of September 2021 Zug, 24. August 2021 – The Longevity Investors Conference targets the
Ichor Life Sciences Acquires Woodland Biosciences, Inc.
December 22, 2021
Woodland Biosciences, which studies metabolism and cancer, has joined the holdings of Ichor Life Sciences. Ichor intends to use Woodland’s expertise and research to increase the specializations of its pharmacological division. The full press release is provided here. LaFayette, N.Y. — Ichor Life Sciences, a premium preclinical
New Partnership Between Forever Healthy and Buck Institute
December 15, 2021
Yet another group has formed to advance early-stage biotechnology research. This time, the Forever Healthy Foundation, founded by Michael Greve, has formed a $5 million partnership with the Buck Institute in order to fund rejuvenation biotechnology. The full press release is included here. Forever Healthy and
Apollo Health Ventures Closes $180 Million Fund
December 2, 2021
Apollo Health Ventures, a venture capitalist firm focusing on rejuvenation biotechnology, has raised $180 million in order to fund companies developing interventions that target age-related diseases. We have included the full press release below. Apollo Health Ventures Closes $180 Million Fund to Drive Breakthrough Innovations Combating
Longevica to Launch an Open Research Platform
November 29, 2021
Longevica, a company focused on the biology of aging, has raised $2.5 million dollars for its platform that it hopes will accelerate life extension research. We have included the full press release below. Longevica to Launch an Open Research Platform to Accelerate the Discovery of Life
Maximon Launches Longevity Co-Investment Fund
October 7, 2021
The venture capitalist firm Maximon has announced a new longevity-focused fund that focuses on financing early-stage biotechnology companies that increase human healthspan. The firm intends to invest 100 million Swiss francs into such companies. The full press release is presented below. Maximon has launched its 100
Transhuman Coin Debuts on International Markets
September 30, 2021
A novel cryptocurrency, Transhuman Coin, has recently announced its debut. When a transaction occurs, this coin is automatically distributed back into funding its own growth and the development of research into cures for various disabilities, including age-related disorders. We at Lifespan.io support Transhuman Coin donations on
The Longevity Science Foundation Launches
September 30, 2021
The Longevity Science Foundation has launched today. This new Swiss foundation has confirmed that it will be committing over $1 billion in the next ten years to research, institutions, and projects advancing healthy human longevity and extending the healthy human lifespan to more than 120 years.
Underdog Pharmaceuticals Concludes $10M Financing Round
September 23, 2021
The investment company Kizoo has announced that one of the companies in its portfolio, Underdog Pharmaceuticals, has received $10 million in funding from a Series Seed II round. Mike Kope, who is well-known for his work in SENS Research Foundation, is the co-CEO of Underdog. As
Underdog Pharmaceuticals Receives Accelerated Designation
September 10, 2021
Underdog Pharmaceuticals (Now called Cyclarity Therapeautics) has just issued a press release announcing that UDP-003, a compound being studied for its effectiveness against oxidized cholesterol, has been given an Innovation Passport under the UK’s Innovative Licensing and Access Pathway program. This is similar to the Fast
The Longevity Investors Conference
August 24, 2021
Press Release The second investors only conference focusing on Longevity will take place on the 27th of September 2021 Zug, 24. August 2021 – The Longevity Investors Conference targets the global investor community and brings private and institutional investors from (U)HNWIs, Family Offices, VCs, Private Equity